Obesity and coronary microvascular disease-implications for adipose tissue-mediated remote inflammatory response

Zsolt Bagi, Zuzana Broskova, Attila Feher

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

It is believed that obesity has detrimental effects on the coronary circulation. These include immediate changes in coronary arterial vasomotor responsiveness and the development of occlusive large coronary artery disease. Despite its critical role in regulating myocardial perfusion, the altered behavior of coronary resistance arteries, which gives rise to coronary microvascular disease (CMD) is poorly understood in obesity. A chronic, low-grade vascular inflammation has been long considered as one of the main underlying pathology behind CMD. The expanded adipose tissue and the infil- trating macrophages are the major sources of pro-inflammatory mediators that have been implicated in causing inadequate myocardial perfusion and, in a long term, development of heart failure in obese patients. Much less is known the mecha- nisms regulating the release of these cytokines into the circulation that enable them to exert their remote effects in the coronary microcirculation. This mini review aims to examine recent studies describing alterations in the vasomotor func- tion of coronary resistance arteries and the role of adipose tissue-derived pro-inflammatory cytokines and adipokines in contributing to CMD in obesity. We provide examples of regulatory mechanisms by which adipokines are released from adipose tissue to exert their remote inflammatory effects on coronary microvessels. We identify some of the important challenges and opportunities going forward.

Original languageEnglish (US)
Pages (from-to)453-461
Number of pages9
JournalCurrent Vascular Pharmacology
Volume12
Issue number3
DOIs
StatePublished - Jan 1 2014

Fingerprint

Coronary Disease
Adipose Tissue
Adipokines
Obesity
Coronary Vessels
Perfusion
Cytokines
Coronary Circulation
Microcirculation
Microvessels
Blood Vessels
Coronary Artery Disease
Heart Failure
Macrophages
Pathology
Inflammation

Keywords

  • Adiponectin
  • Adipose tissue
  • Coronary artery
  • IL-6
  • Leptin
  • Obesity
  • Resistin
  • TNF

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Obesity and coronary microvascular disease-implications for adipose tissue-mediated remote inflammatory response. / Bagi, Zsolt; Broskova, Zuzana; Feher, Attila.

In: Current Vascular Pharmacology, Vol. 12, No. 3, 01.01.2014, p. 453-461.

Research output: Contribution to journalArticle

@article{fa63ce08ef49466690143e31e523a989,
title = "Obesity and coronary microvascular disease-implications for adipose tissue-mediated remote inflammatory response",
abstract = "It is believed that obesity has detrimental effects on the coronary circulation. These include immediate changes in coronary arterial vasomotor responsiveness and the development of occlusive large coronary artery disease. Despite its critical role in regulating myocardial perfusion, the altered behavior of coronary resistance arteries, which gives rise to coronary microvascular disease (CMD) is poorly understood in obesity. A chronic, low-grade vascular inflammation has been long considered as one of the main underlying pathology behind CMD. The expanded adipose tissue and the infil- trating macrophages are the major sources of pro-inflammatory mediators that have been implicated in causing inadequate myocardial perfusion and, in a long term, development of heart failure in obese patients. Much less is known the mecha- nisms regulating the release of these cytokines into the circulation that enable them to exert their remote effects in the coronary microcirculation. This mini review aims to examine recent studies describing alterations in the vasomotor func- tion of coronary resistance arteries and the role of adipose tissue-derived pro-inflammatory cytokines and adipokines in contributing to CMD in obesity. We provide examples of regulatory mechanisms by which adipokines are released from adipose tissue to exert their remote inflammatory effects on coronary microvessels. We identify some of the important challenges and opportunities going forward.",
keywords = "Adiponectin, Adipose tissue, Coronary artery, IL-6, Leptin, Obesity, Resistin, TNF",
author = "Zsolt Bagi and Zuzana Broskova and Attila Feher",
year = "2014",
month = "1",
day = "1",
doi = "10.2174/1570161112666140423221843",
language = "English (US)",
volume = "12",
pages = "453--461",
journal = "Current Vascular Pharmacology",
issn = "1570-1611",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - Obesity and coronary microvascular disease-implications for adipose tissue-mediated remote inflammatory response

AU - Bagi, Zsolt

AU - Broskova, Zuzana

AU - Feher, Attila

PY - 2014/1/1

Y1 - 2014/1/1

N2 - It is believed that obesity has detrimental effects on the coronary circulation. These include immediate changes in coronary arterial vasomotor responsiveness and the development of occlusive large coronary artery disease. Despite its critical role in regulating myocardial perfusion, the altered behavior of coronary resistance arteries, which gives rise to coronary microvascular disease (CMD) is poorly understood in obesity. A chronic, low-grade vascular inflammation has been long considered as one of the main underlying pathology behind CMD. The expanded adipose tissue and the infil- trating macrophages are the major sources of pro-inflammatory mediators that have been implicated in causing inadequate myocardial perfusion and, in a long term, development of heart failure in obese patients. Much less is known the mecha- nisms regulating the release of these cytokines into the circulation that enable them to exert their remote effects in the coronary microcirculation. This mini review aims to examine recent studies describing alterations in the vasomotor func- tion of coronary resistance arteries and the role of adipose tissue-derived pro-inflammatory cytokines and adipokines in contributing to CMD in obesity. We provide examples of regulatory mechanisms by which adipokines are released from adipose tissue to exert their remote inflammatory effects on coronary microvessels. We identify some of the important challenges and opportunities going forward.

AB - It is believed that obesity has detrimental effects on the coronary circulation. These include immediate changes in coronary arterial vasomotor responsiveness and the development of occlusive large coronary artery disease. Despite its critical role in regulating myocardial perfusion, the altered behavior of coronary resistance arteries, which gives rise to coronary microvascular disease (CMD) is poorly understood in obesity. A chronic, low-grade vascular inflammation has been long considered as one of the main underlying pathology behind CMD. The expanded adipose tissue and the infil- trating macrophages are the major sources of pro-inflammatory mediators that have been implicated in causing inadequate myocardial perfusion and, in a long term, development of heart failure in obese patients. Much less is known the mecha- nisms regulating the release of these cytokines into the circulation that enable them to exert their remote effects in the coronary microcirculation. This mini review aims to examine recent studies describing alterations in the vasomotor func- tion of coronary resistance arteries and the role of adipose tissue-derived pro-inflammatory cytokines and adipokines in contributing to CMD in obesity. We provide examples of regulatory mechanisms by which adipokines are released from adipose tissue to exert their remote inflammatory effects on coronary microvessels. We identify some of the important challenges and opportunities going forward.

KW - Adiponectin

KW - Adipose tissue

KW - Coronary artery

KW - IL-6

KW - Leptin

KW - Obesity

KW - Resistin

KW - TNF

UR - http://www.scopus.com/inward/record.url?scp=84922391966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922391966&partnerID=8YFLogxK

U2 - 10.2174/1570161112666140423221843

DO - 10.2174/1570161112666140423221843

M3 - Article

C2 - 24846234

AN - SCOPUS:84922391966

VL - 12

SP - 453

EP - 461

JO - Current Vascular Pharmacology

JF - Current Vascular Pharmacology

SN - 1570-1611

IS - 3

ER -